> 89 Infecciones fúngicas. Profilaxis y tratamiento BIBLIOGRAFÍA 1. Vallejo Llamas JC, Ruiz-Camps I. Infección fúngica invasora en los pacientes hematológicos. Enferm Infecc Microbiol Clin. 2012;30(9):572-9. 2. Taplitz RA, Kennedy EB, Bow EJ, Crews J , Gleason C , Hawley DK, et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol. 2018;36(30):3043-54. 3. Angarone M. Fungal Infections in Cancer Patients. Cancer Treat Res. 2014;161:129-55. 4. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/ MSG) consensus group. Clin Infect Dis. 2008;46:1813-21. 5. Mousset S, Buchheidt D, Heinz W, Ruhnke M, Cornely OA, Egerer G, et al. Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2014 Jan;93(1):13-32. 6. Cooley L, Dendle C, Wolf J, Teh BW, Chen SC, Boutlis C, et al. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies. Intern Med J. 2014 Dec;44(12b):1350-63.
RkJQdWJsaXNoZXIy OTI4NTYw